- Report
- March 2020
- 101 Pages
Global
From €4324EUR$4,500USD£3,697GBP
- Report
- September 2022
- 220 Pages
Global
From €5506EUR$5,730USD£4,707GBP
- Report
- April 2019
- 187 Pages
Global
From €5160EUR$5,370USD£4,411GBP
- Report
- May 2021
- 376 Pages
Global
From €5926EUR$6,168USD£5,067GBP
- Report
- May 2023
- 147 Pages
Global
From €5764EUR$5,999USD£4,928GBP
The Artificial Tear market within the Optical industry is a segment of the larger eye care market. It is composed of products designed to lubricate and moisturize the eyes, providing relief from dryness and irritation. Artificial tears are available in a variety of forms, including drops, gels, ointments, and sprays. They are typically used to treat dry eye syndrome, a condition caused by a lack of tear production. Artificial tears can also be used to treat other eye conditions, such as allergies, blepharitis, and contact lens discomfort.
The Artificial Tear market is highly competitive, with a range of products available from both large and small companies. Some of the major players in the market include Allergan, Bausch + Lomb, Novartis, and Johnson & Johnson. Other companies include Alcon, Santen, and Ocular Science. Show Less Read more